These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25387974)

  • 1. Human cytochrome P450 and personalized medicine.
    Chen Q; Wei D
    Adv Exp Med Biol; 2015; 827():341-51. PubMed ID: 25387974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in human cytochrome p450 and personalized medicine.
    Chen Q; Zhang T; Wang JF; Wei DQ
    Curr Drug Metab; 2011 Jun; 12(5):436-44. PubMed ID: 21453272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Cancer Therapy Considering Cytochrome P450 Variability.
    Preissner S; Simmaco M; Gentile G; Preissner R
    Adv Pharmacol; 2015; 74():113-30. PubMed ID: 26233905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 variations in different ethnic populations.
    McGraw J; Waller D
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):371-82. PubMed ID: 22288606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
    Preissner SC; Hoffmann MF; Preissner R; Dunkel M; Gewiess A; Preissner S
    PLoS One; 2013; 8(12):e82562. PubMed ID: 24340040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PERSONALIZED MEDICINE IN INTERNAL MEDICINE].
    Kukes VG; Marinin VF; Olefir YV; Ramenskaya GV; Lazareva NB; Smirnov VV; Zhuravleva MV; Prokofiev AB; Shih EV; Zhestovskaia AS; Rumyantsev NA; Mandich DV; Goroshko OA
    Klin Med (Mosk); 2017; 95(3):197-200. PubMed ID: 30303336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism.
    Annalora AJ; Marcus CB; Iversen PL
    Drug Metab Dispos; 2017 Apr; 45(4):375-389. PubMed ID: 28188297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics: New Frontier in Personalized Medicine.
    Sneha P; Doss CG
    Adv Protein Chem Struct Biol; 2016; 102():181-224. PubMed ID: 26827606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCYPPred: a web-based predictor of SNPs for human cytochrome P450.
    Li L; Wei DQ; Wang JF; Chou KC
    Protein Pept Lett; 2012 Jan; 19(1):57-61. PubMed ID: 21919859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue].
    Jiang JH; Jia WH; Qin HD; Liang H; Pan ZG; Zeng YX
    Ai Zheng; 2004 Jun; 23(6):672-7. PubMed ID: 15191668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved feature-based prediction of SNPs in human cytochrome P450 enzymes.
    Li L; Xiong Y; Zhang ZY; Guo Q; Xu Q; Liow HH; Zhang YH; Wei DQ
    Interdiscip Sci; 2015 Mar; 7(1):65-77. PubMed ID: 25792441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Toxicology.
    Schwarz DA; George MP; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):693-707. PubMed ID: 27842787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress on bioinformatics, functional genomics, and metabolomics research of cytochrome P450 and its impact on drug discovery.
    Zhang T; Zhao M; Pang Y; Zhang W; Angela Liu L; Wei DQ
    Curr Top Med Chem; 2012; 12(12):1346-55. PubMed ID: 22690681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.
    Schwaiblmair M; Behr W; Foerg W; Berghaus T
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1547-60. PubMed ID: 22070131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.